The NPF is a nonprofit organization well known for its work in seeking out misleading dietary supplement ads and contacting responsible manufacturers to correct those ads.
The Natural Products Foundation (NPF; Washington, DC) is reporting that an October meeting with FDA’s Dan Fabricant provided the organization with valuable information for how to improve NPF’s Truth in Advertising program.
The NPF is a nonprofit organization well known for its work in seeking out misleading dietary supplement ads and contacting responsible manufacturers to correct those ads. When manufacturers fail to comply, the NPF notifies FDA and the FTC.
From 2010–2011, NPF referred 25 cases of misleading advertisements to federal agencies.
The NPF is now reporting that, at the 2011 SupplySide West trade show in Las Vegas, NPF’s board of directors met with Dan Fabricant, director of FDA’s Division of Dietary Supplement Programs, to discuss the Truth in Advertising Program.
“The information about FDA’s dietary supplement program priorities and initiatives that Dr. Fabricant was able to share with the Board will be of great assistance in helping us make our programs even more effective,” said Marc Ullman, chairman of the NPF Legal Advisory Council.
Check out the Natural Products Foundation online for resources on responsible advertising campaigns and more information about the Truth in Advertising program.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.